N/A
N=32
Feasibility Study of a Novel mHealth Application to Enable Community Health Workers to Manage
Hypertension
Bottom Line
View on ClinicalTrials.gov: NCT05479097 ↗Enrolled (actual)
32
Serious AEs
0.0%
Results posted
Jul 2024
Primary outcome: Primary: Change in Systolic Blood Pressure — -7.5 mmHg — p=0.03232
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Anti-Hypertensive (Drug)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- University of Wisconsin, Madison
- Primary completion
- Aug 2023
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Change in Systolic Blood Pressure |
-7.5 | 0.03232 sig |
| PRIMARY Difference in Diastolic Blood Pressure From Baseline to 6 Months |
-3.1 | 0.045 sig |
| PRIMARY Change in the Proportion of Patients With Systolic Blood Pressure Less Than or Equal to 140 |
21; 9; 23; 7 | 0.7237 |
| PRIMARY Change in the Proportion of Patients With Systolic Blood Pressure Less Than or Equal to Personalized Goal |
21; 9; 23; 7 | 0.7237 |
| PRIMARY Proportion of Visits for Which Both the CHW Conducting the Visit and the Physician Reviewing Post-visit Data Agreed With the Antihypertensive Recommendations Provided by the CDS Application |
202; 7 | — |
Summary
This is a single group study assessing the feasibility of hypertension management by community health workers (CHWs) equipped with a mobile clinical decision support (CDS) application and working with remote physician supervision.
Eligibility Criteria
Inclusion Criteria
- Greater than 18 years old
- Diagnosed with hypertension
- Blood pressure greater than or equal to 140/90 mm Hg OR
- currently taking antihypertensive medication
Exclusion Criteria
- Pregnancy
- Severe comorbid condition(s) with life expectancy less than 1 year
Data sourced from ClinicalTrials.gov (NCT05479097). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.